Week In Review: Supply ConSTRAINts US equity indexes were up on the week: DJIA +0.6%, S&P 500 +1.9%, NASDAQ +4.2%. Wednesday was US Inauguration Day – Joe Biden was sworn in as the 46th President of the United States and Kamala Harris as the Vice President. On Friday, the US…
Week In Review: Political Uncertainty US equity indexes were lower on the week: DJIA -0.9%, S&P 500 -1.5%, NASDAQ -1.5%, due to political uncertainty, disappointing US economic data, and as the market waited for President-elect Joe Biden’s fiscal stimulus plan. Details of the $1.9 trillion plan came late in the…
Week In Review: Off to a Busy Start US equity indexes were higher on the week: DJIA +1.6%, S&P 500 +1.8%, NASDAQ +2.4%. Democratic Senate candidates won their respective races in Georgia, giving the Democratic party a Senate majority. Wednesday’s turmoil at the US Capitol, which interrupted the counting of…
Week In Review: The Roll-Out US equity indexes were higher on the week: DJIA +1.3%, S&P 500 +1.4%, NASDAQ +0.7%. It was a holiday shortened trading week. The market focused on the size of the US stimulus bill, the rising coronavirus case count as well as the new strain of…
Week In Review: A Second Vaccine US equity indexes were higher on the week: DJIA +0.4%, S&P 500 +1.3%, NASDAQ +3.1%. All three indexes hit all time highs. Optimism that an additional US fiscal stimulus deal will get done along with continued positive news on the vaccine front supported sentiment.…
Week In Review: The First US equity indexes were lower on the week: DJIA -0.6%, S&P 500 -1.0%, NASDAQ -0.7%. Drawn out negotiations between the Republicans and Democrats on another round of fiscal stimulus, and worse than expected initial jobless claims weighed on sentient. On Tuesday, December 8th, the…
US equity indexes were up on the week: DJIA +1.0%. S&P 500 +1.7%, NASDAQ +2.1%. On Wednesday, the UK became the first Western country to approve a Covid-19 vaccine when its regulator cleared the Pfizer/BioNTech vaccine. Pfizer put out a press release titled: “Pfizer and BioNTech Achieve First Authorization in the World for a…
US equity indexes were up for this holiday-shortened week: DJIA +2.2%. The Dow broke above 30,000 for the first time. S&P 500 +2.3 %, NASDAQ +3.0%. On Monday, AstraZeneca and University of Oxford released the results of their vaccine trial reporting, “One dosing regimen (n=2,741) showed vaccine efficacy of…
This week brought more positive news on the vaccine front. On Monday, Moderna announced that its Phase 3 study of mRNA-1273, its vaccine candidate against COVID-19, “has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%.” On Friday, Pfizer and BioNTech applied…
On Monday, Pfizer and BioNtech announced that their “vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis.” In this interview, Axios speaks with Pfizer CEO Albert Bourla about vaccine data, distribution, politics, and how he…
US equity indexes rose strongly this week: DJIA +6.9%, S&P 500 +7.3%, and NASDAQ +9.0%. At the time of writing on Saturday, major news networks are calling the US Presidential Election for VP Biden. However, during the past week post- US Election Day and while markets were open, the US Presidential…
US equity indexes were down on the week: DJIA -6.5%, S&P 500 -5.6% and NASDAQ -5.5%. The losses were driven by US election uncertainty, rising COVID-19 cases in the US and Europe and the new lockdown measures being taken there to try to control the virus’s spread. The US has…